• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向生长分化因子11的过氧化物酶体增殖物激活受体在动脉粥样硬化模型中抑制血管内皮细胞衰老

PPAR Targeting GDF11 Inhibits Vascular Endothelial Cell Senescence in an Atherosclerosis Model.

作者信息

Dou Fangfang, Wu Beiling, Chen Jiulin, Liu Te, Yu Zhihua, Chen Chuan

机构信息

Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200031, China.

出版信息

Oxid Med Cell Longev. 2021 Feb 25;2021:2045259. doi: 10.1155/2021/2045259. eCollection 2021.

DOI:10.1155/2021/2045259
PMID:33728018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7935606/
Abstract

Atherosclerosis (AS) is a complex vascular disease that seriously harms the health of the elderly. It is closely related to endothelial cell aging, but the role of senescent cells in atherogenesis remains unclear. Studies have shown that peroxisome proliferator-activated receptor alpha (PPAR) inhibits the development of AS by regulating lipid metabolism. Our previous research showed that PPAR was involved in regulating the repair of damaged vascular endothelial cells. Using molecular biology and cell biology approaches to detect senescent cells in atherosclerosis-prone apolipoprotein E-deficient ( ) mice, we found that PPAR delayed atherosclerotic plaque formation by inhibiting vascular endothelial cell senescence, which was achieved by regulating the expression of growth differentiation factor 11 (GDF11). GDF11 levels declined with age in several organs including the myocardium, bone, central nervous system, liver, and spleen in mice and participated in the regulation of aging. Our results showed that PPAR inhibited vascular endothelial cell senescence and apoptosis and promoted vascular endothelial cell proliferation and angiogenesis by increasing GDF11 production. Taken together, these results demonstrated that PPAR inhibited vascular endothelial cell aging by promoting the expression of the aging-related protein GDF11, thereby delaying the occurrence of AS.

摘要

动脉粥样硬化(AS)是一种严重危害老年人健康的复杂血管疾病。它与内皮细胞衰老密切相关,但衰老细胞在动脉粥样硬化发生过程中的作用仍不清楚。研究表明,过氧化物酶体增殖物激活受体α(PPAR)通过调节脂质代谢抑制AS的发展。我们之前的研究表明,PPAR参与调节受损血管内皮细胞的修复。利用分子生物学和细胞生物学方法检测易患动脉粥样硬化的载脂蛋白E缺陷( )小鼠中的衰老细胞,我们发现PPAR通过抑制血管内皮细胞衰老来延迟动脉粥样硬化斑块形成,这是通过调节生长分化因子11(GDF11)的表达实现的。在小鼠的几个器官中,包括心肌、骨骼、中枢神经系统、肝脏和脾脏,GDF11水平随年龄下降并参与衰老调节。我们的结果表明,PPAR通过增加GDF11的产生来抑制血管内皮细胞衰老和凋亡,并促进血管内皮细胞增殖和血管生成。综上所述,这些结果表明PPAR通过促进衰老相关蛋白GDF11的表达来抑制血管内皮细胞衰老,从而延缓AS的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/c84c027f3922/OMCL2021-2045259.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/d3c3aeec1329/OMCL2021-2045259.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/89ceb00e93f9/OMCL2021-2045259.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/47c0502d6793/OMCL2021-2045259.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/a2e5ba14dea6/OMCL2021-2045259.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/2f6e4c331b74/OMCL2021-2045259.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/c84c027f3922/OMCL2021-2045259.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/d3c3aeec1329/OMCL2021-2045259.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/89ceb00e93f9/OMCL2021-2045259.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/47c0502d6793/OMCL2021-2045259.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/a2e5ba14dea6/OMCL2021-2045259.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/2f6e4c331b74/OMCL2021-2045259.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9a/7935606/c84c027f3922/OMCL2021-2045259.006.jpg

相似文献

1
PPAR Targeting GDF11 Inhibits Vascular Endothelial Cell Senescence in an Atherosclerosis Model.靶向生长分化因子11的过氧化物酶体增殖物激活受体在动脉粥样硬化模型中抑制血管内皮细胞衰老
Oxid Med Cell Longev. 2021 Feb 25;2021:2045259. doi: 10.1155/2021/2045259. eCollection 2021.
2
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.双重过氧化物酶体增殖物激活受体α/γ激动剂阿格列扎增加内皮祖细胞的数量和功能:对血管功能和动脉粥样硬化形成的影响。
Br J Pharmacol. 2014 May;171(10):2685-703. doi: 10.1111/bph.12608.
3
Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.过氧化物酶体增殖物激活受体-α基因水平差异影响载脂蛋白 E2 基因敲入小鼠的脂代谢和炎症反应。
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1573-9. doi: 10.1161/ATVBAHA.110.220525. Epub 2011 Apr 7.
4
TERT assists GDF11 to rejuvenate senescent VEGFR2/CD133 cells in elderly patients with myocardial infarction.TERT 协助 GDF11 使老年心梗患者中衰老的 VEGFR2/CD133 细胞年轻化。
Lab Invest. 2019 Nov;99(11):1661-1688. doi: 10.1038/s41374-019-0290-1. Epub 2019 Jul 10.
5
Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.艾塞那肽缓解慢性应激下载脂蛋白 E 缺陷小鼠饮食诱导的血管衰老和动脉粥样硬化斑块生长。
Atherosclerosis. 2017 Sep;264:1-10. doi: 10.1016/j.atherosclerosis.2017.07.014. Epub 2017 Jul 13.
6
Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.内皮细胞特异性缺失P2Y2受体可促进动脉粥样硬化易感载脂蛋白E基因敲除小鼠的斑块稳定性。
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):75-83. doi: 10.1161/ATVBAHA.116.308561. Epub 2016 Nov 17.
7
GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice.生长分化因子11可保护载脂蛋白E基因敲除小鼠免受内皮损伤并减少动脉粥样硬化病变形成。
Mol Ther. 2016 Nov;24(11):1926-1938. doi: 10.1038/mt.2016.160. Epub 2016 Aug 9.
8
Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells.生长分化因子 11 促进肺动脉内皮细胞异常增殖和血管生成。
Hypertension. 2018 Apr;71(4):729-741. doi: 10.1161/HYPERTENSIONAHA.117.10350. Epub 2018 Feb 20.
9
Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.精氨酸酶-II 通过 p66Shc 和 p53 诱导血管平滑肌细胞衰老和凋亡,不依赖其 l-精氨酸脲酶活性:对动脉粥样硬化斑块易损性的影响。
J Am Heart Assoc. 2013 Jul 5;2(4):e000096. doi: 10.1161/JAHA.113.000096.
10
Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis.Notch 激活诱导内皮细胞衰老和促炎反应:Notch 信号在动脉粥样硬化中的作用。
Atherosclerosis. 2012 Dec;225(2):296-303. doi: 10.1016/j.atherosclerosis.2012.04.010. Epub 2012 May 18.

引用本文的文献

1
Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.依折麦布与他汀类药物联合治疗高脂血症的系统评价和荟萃分析方案
PLoS One. 2024 Dec 23;19(12):e0312588. doi: 10.1371/journal.pone.0312588. eCollection 2024.
2
How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.过氧化物酶体增殖物激活受体-α(PPAR-α)介导的炎症如何影响慢性肾脏病的病理生理学。
Curr Res Physiol. 2024 Nov 14;8:100133. doi: 10.1016/j.crphys.2024.100133. eCollection 2025.
3
Peroxisome Proliferator-Activated Receptor α/γ and Cannabinoid Receptor 2 Agonist Attenuated Nonalcoholic Steatohepatitis Exosome-Related Abnormalities in Mice.

本文引用的文献

1
Identification of a novel regulatory pathway for PPARα by RNA-seq characterization of the endothelial cell lipid peroxidative injury transcriptome.通过 RNA-seq 分析内皮细胞脂质过氧化损伤转录组鉴定 PPARα 的新型调控途径。
Open Biol. 2019 Dec;9(12):190141. doi: 10.1098/rsob.190141. Epub 2019 Dec 18.
2
The Role of Signaling Pathways of Inflammation and Oxidative Stress in Development of Senescence and Aging Phenotypes in Cardiovascular Disease.炎症和氧化应激信号通路在心血管疾病衰老表型发生发展中的作用。
Cells. 2019 Nov 4;8(11):1383. doi: 10.3390/cells8111383.
3
Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury.
过氧化物酶体增殖物激活受体α/γ与大麻素受体2激动剂减轻小鼠非酒精性脂肪性肝炎中与外泌体相关的异常。
Am J Pathol. 2025 Feb;195(2):188-203. doi: 10.1016/j.ajpath.2024.10.006. Epub 2024 Oct 26.
4
PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets.动脉粥样硬化中的过氧化物酶体增殖物激活受体:从机制到可成药靶点的时空特征
J Adv Res. 2025 Mar;69:225-244. doi: 10.1016/j.jare.2024.03.020. Epub 2024 Mar 29.
5
Insights into bone morphogenetic proteins in cardiovascular diseases.心血管疾病中骨形态发生蛋白的研究进展
Front Pharmacol. 2023 Feb 23;14:1125642. doi: 10.3389/fphar.2023.1125642. eCollection 2023.
6
Correlation Between GDF11 Serum Levels, Severity of Coronary Artery Lesions, and the Prognosis of Patients with ST-segment Elevation Myocardial Infarction.ST段抬高型心肌梗死患者血清生长分化因子11水平、冠状动脉病变严重程度与预后的相关性
J Cardiovasc Transl Res. 2023 Aug;16(4):938-947. doi: 10.1007/s12265-023-10358-w. Epub 2023 Feb 7.
7
Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway.非诺贝特通过过氧化物酶体增殖物激活受体α(PPARα)信号通路调节脂质代谢,从而抑制角膜新生血管形成。
Front Pharmacol. 2022 Dec 16;13:1000254. doi: 10.3389/fphar.2022.1000254. eCollection 2022.
8
The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease.在环孢素A诱导的慢性肾脏病小鼠模型中,UGT1A1反义寡核苷酸疗法介导的生理性非结合性高胆红素血症的潜在保护作用及潜在机制
Metabolites. 2022 Oct 20;12(10):999. doi: 10.3390/metabo12100999.
9
Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging.影响血管衰老过程中内皮细胞衰老的因素及通路。
Int J Mol Sci. 2022 Sep 4;23(17):10135. doi: 10.3390/ijms231710135.
10
Mechanisms and consequences of endothelial cell senescence.内皮细胞衰老的机制和后果。
Nat Rev Cardiol. 2023 Jan;20(1):38-51. doi: 10.1038/s41569-022-00739-0. Epub 2022 Jul 19.
外源性 GDF11 减弱非经典 TGF-β 信号转导,从而保护心脏免受急性心肌缺血再灌注损伤。
Basic Res Cardiol. 2019 Mar 21;114(3):20. doi: 10.1007/s00395-019-0728-z.
4
Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events.内源性因子的再生能力:生长分化因子 11;一种管理与年龄相关心血管事件的新方法。
Int J Mol Sci. 2018 Dec 12;19(12):3998. doi: 10.3390/ijms19123998.
5
Molecular Actions of PPARα in Lipid Metabolism and Inflammation.PPARα 在脂质代谢和炎症中的分子作用。
Endocr Rev. 2018 Oct 1;39(5):760-802. doi: 10.1210/er.2018-00064.
6
Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.通心络通过激活过氧化物酶体增殖物激活受体-α通路减轻血管生成素样蛋白 4 介导的内皮屏障完整性损伤,从而减轻糖尿病心脏的再灌注损伤。
PLoS One. 2018 Jun 18;13(6):e0198403. doi: 10.1371/journal.pone.0198403. eCollection 2018.
7
A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.一种新型选择性过氧化物酶体增殖物激活受体α调节剂(SPPARMα),K-877(非诺贝特),可减轻小鼠餐后高甘油三酯血症。
J Atheroscler Thromb. 2018 Feb 1;25(2):142-152. doi: 10.5551/jat.39693. Epub 2017 Aug 5.
8
Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.外源性生长分化因子11会导致心脏和骨骼肌功能障碍及萎缩。
Basic Res Cardiol. 2017 Jul;112(4):48. doi: 10.1007/s00395-017-0639-9. Epub 2017 Jun 24.
9
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.过氧化物酶体增殖物激活受体(PPARs):代谢调节因子及心血管疾病的治疗靶点。第一部分:PPAR-α
Future Cardiol. 2017 May;13(3):259-278. doi: 10.2217/fca-2016-0059. Epub 2017 Jun 5.
10
From arterial ageing to cardiovascular disease.从动脉老化到心血管疾病。
Lancet. 2017 Apr 29;389(10080):1676-1678. doi: 10.1016/S0140-6736(17)30763-8.